TDAG8 Activators
TDAG8 Activators are a diverse group of compounds that enhance the functional activity of TDAG8 through indirect pathways and signaling events. Forskolin, by elevating cAMP, and Prostaglandin E2, through its receptor-mediated effects, both converge on the cAMP/PKA signaling axis to potentiate TDAG8's activity. Similarly, IBMX, by inhibiting the degradation of cAMP, and Epinephrine, through adrenergic receptor stimulation, lead to increased PKA activity, which can phosphorylate and activate proteins involved in the TDAG8 signaling cascade. Lactic Acid, by altering intracellular pH, can modulate the activity of the pH-sensitive TDAG8, while Sphingosine-1-phosphate can activate G-protein signaling pathways that may cross-communicate with TDAG8-related pathways. The stable cAMP analog 8-Bromoadenosine cAMP, and Adenosine, through adenosine receptor engagement, both elevate cAMP levels, further enhancing TDAG8 signaling.
TDAG8 activators comprise a spectrum of chemical agents that work through various signaling pathways to enhance the activity of TDAG8. Forskolin, known to raise intracellular cAMP, indirectly fosters TDAG8 function by enabling PKA activation, which in turn can phosphorylate key proteins in TDAG8's signaling pathway. Prostaglandin E2 interacts with its receptors to activate adenylate cyclase, similarly increasing cAMP and indirectly promoting TDAG8 activity through PKA-mediated crosstalk. IBMX further supports this mechanism by inhibiting cAMP degradation, thereby sustaining PKA activation and enhancing TDAG8 signaling. Additionally, the physiological effects of Lactic Acid and Sphingosine-1-phosphate play a role in modulating G-protein coupled receptors, which can amplify TDAG8's function through associated intracellular pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances TDAG8 activity by increasing intracellular cAMP levels, which can lead to the activation of protein kinase A (PKA). PKA can phosphorylate TDAG8 or associated regulatory proteins, thereby enhancing TDAG8 signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 binds to its receptors, which can result in the activation of adenylate cyclase, increasing cAMP levels and PKA activity, thereby indirectly enhancing TDAG8 signaling pathways through crosstalk. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) acts as a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels and subsequent activation of PKA, potentially enhancing the functional activity of TDAG8. | ||||||
Lactic acid | 50-21-5 | sc-215227 sc-215227A | 100 ml 500 ml | $102.00 $179.00 | 1 | |
Lactic Acid, as a result of its role in intracellular pH reduction, can modulate G-protein coupled receptor activity, including TDAG8, which is known to be pH-sensitive. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate can influence G-protein coupled receptor signaling and potentially increase the activity of TDAG8 through intracellular signaling cascade modulation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors leading to increased cAMP production and activation of PKA, which may indirectly enhance TDAG8 signaling through secondary messenger pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromoadenosine cAMP is a stable cAMP analog that activates PKA and can enhance TDAG8 signaling by mimicking the action of cAMP in the cell. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine interacts with its receptors to increase cAMP levels in certain cells, thereby potentially enhancing TDAG8 activity through PKA signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate its G-protein coupled receptors leading to diverse signaling outcomes, including the potential enhancement of TDAG8 activity through modulation of intracellular signaling pathways. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Bicuculline, as a GABA_A receptor antagonist, can influence intracellular chloride levels and neuronal excitability, indirectly affecting TDAG8 signaling in neurons. | ||||||